The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype
Open accessAbstract
CD163 is a member of the scavenger receptor cysteine-rich superfamily restricted to the monocyte/macrophage lineage and is thought to be a useful marker for anti-inflammatory or alternatively activated macrophages. In this study we used mass spectrometric analysis to determine that the antigen recognized by the antibody AM-3K, which we previously generated as a tissue macrophage-specific monoclonal antibody, was CD163. An anti-inflammatory subtype of macrophages stimulated by dexamethasone or interleukin-10 showed strong reactivity for AM-3K and increased expression of CD163 mRNA. Immunohistochemical staining of routinely processed pathological specimens revealed that AM-3K recognized a specialized subpopulation of macrophages. In granulomatous diseases such as tuberculosis, sarcoidosis, or foreign body reactions, tissue macrophages around granulomas, but not component cells of the granulomas such as epithelioid cells and multinucleated giant cells, showed positive staining for AM-3K. In atherosclerotic lesions, scattered macrophages in diffuse intimal lesions were strongly positive for AM-3K, whereas foamy macrophages in atheromatous plaques demonstrated only weak staining. We therefore suggest that, in routine pathological specimens, AM-3K is a useful marker for anti-inflammatory macrophages because these cells can be distinguished from inflammatory or classically activated macrophages. Because AM-3K cross-reacts with macrophage subpopulations in different animal species including rats, guinea pigs, rabbits, cats, dogs, goats, pigs, bovine species, horses, monkeys, and cetaceans, it will have wide application for detection of CD163 in various animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
The many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902 · cited 1×
“…expressed by alternatively activated macrophages, whereas tumor necrosis factor-a (TNF-a), IL-1b, IL-6, IL-12, and inducible nitric oxide synthase (iNOS) showed restricted expression by these macrophages (Goerdt and Orfanos 1999; Gordon 2003; Mosser 2003; Mantovani et al. 2004; Taylor et al. 2005).”
BackgroundBer-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen.
Backé, E., Schwarting, R., Gerdes, J., Ernst, M., & Stein, H. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.11.936 · Cited by 92
Cited by
Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008) · The Journal of Pathology · doi:10.1002/path.2370 · Cited by 738
Self-citationClinical significance of macrophage heterogeneity in human malignant tumors
Komohara, Y., Jinushi, M., & Takeya, M. (2014) · Cancer Science · doi:10.1111/cas.12314 · Cited by 551
Self-citationThe endometrial immune environment of women with endometriosis
Vallvé-Juanico, J., Houshdaran, S., & Giudice, L. C. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz018 · Cited by 524
Burkard, C., Lillico, S. G., Reid, E., Jackson, B., Mileham, A. J., Ait-Ali, T., Whitelaw, C. B. A., & Archibald, A. L. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006206 · Cited by 378
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
Van Gorp, H., Delputte, P. L., & Nauwynck, H. J. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.008 · Cited by 357
Metadata
- Authors
- Komohara, Y., Hirahara, J., Horikawa, T., Kawamura, K., Kiyota, E., Sakashita, N., Araki, N., & Takeya, M.
- Venue
- Journal of Histochemistry & Cytochemistry
- Publisher
- SAGE Publications
- Published
- 2006-07
- Volume
- 54
- Issue
- 7
- Pages
- 763-771
- ISSN
- 0022-1554 (ISSN-L)
- 1551-5044
- OpenAlex
- W2138420245
- Cited by
- 172
- References
- 4
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype. https://app.cochat.ai/papers/10.1369/jhc.5a6871.2006
- The paper
- Komohara, Y., Hirahara, J., Horikawa, T., Kawamura, K., Kiyota, E., Sakashita, N., Araki, N., & Takeya, M. (2006). AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype. Journal of Histochemistry & Cytochemistry. https://doi.org/10.1369/jhc.5a6871.2006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.